| Net Cash Provided by (Used in) Operating Activities |
$185,468 |
USD |
7.1% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$325,000 |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$150,000 |
USD |
-100% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
15,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
1,846,250 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$371,603 |
USD |
7273% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
$697,269 |
USD |
38% |
Q3 2025 |
Q2 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$693,600 |
USD |
42% |
Q3 2025 |
Q2 2026 |
| Deferred Income Tax Expense (Benefit) |
$400 |
USD |
94% |
Q2 2025 |
Q1 2026 |
| Deferred Federal Income Tax Expense (Benefit) |
$12,027 |
USD |
-177% |
Q3 2025 |
Q2 2026 |
| Current Federal Tax Expense (Benefit) |
$175,237 |
USD |
-67% |
Q3 2025 |
Q2 2026 |
| Interest Expense |
$50,000 |
USD |
0% |
Q2 2025 |
Q1 2026 |